Kura Oncology
Kura Oncology is seeking a Vice President, Clinical Development (MD) to lead cross-functional teams and oversee the design and conduct of oncology clinical studies. The role involves strategic decision-making, collaboration with various departments, and ensuring scientific and regulatory excellence in drug development. This is a leadership position within a biopharmaceutical company focused on precision cancer therapies.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2014
Kura Oncology is a precision oncology biotechnology company focused on realizing the promise of targeted medicines to help patients with cancer lead better, longer lives. The company discovers and develops small-molecule therapies designed to inhibit specific cancer-driving pathways and genetic alterations, advancing programs through preclinical and clinical development. Kura works with clinical investigators and partners to test its candidates in genetically defined patient populations with the goal of delivering meaningful, durable treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kura Oncology.
Kura Oncology Inc. Q4 Loss Increases
1 week ago
Vice President, Clinical Development
Tarsus Pharmaceuticals
Vice President, Clinical Development
Precision for Medicine
Vice President, Clinical Development
Lyell Immunopharma
Vice President , Global Clinical Lead - Solid Tumor
Takeda Pharmaceutical Company Limited
Clinical Director Oncology (Principal Scientist, MD)
MSD
Associate Director, Clinical Scientist, Oncology
Regeneron Pharmaceuticals